The Future Of Clinical Trials: How AI, Big Tech, & Covid-19 Could Make Drug Development Cheaper, Faster, & More Effective

The Future Of Clinical Trials: The Promise Of AI And The Role Of Big Tech

Testing new drugs is a slow and expensive process. AI has the potential to disrupt clinical trials – from patient recruitment to adherence monitoring and data collection – and Covid-19 has catalyzed its adoption. In the past year , nearly 5,000 clinical trials were launched to test life-saving treatments and vaccines for the novel coronavirus.